The Burmans recently announced their intentions to acquire a majority stake in Religare through an open offer. Current management seems to be in no mood to let go of control. With multiple regulatory clearances due, the takeover could be a long drawn affair. Amid all this, Ventura Securities report pegging the share price target at INR471, has ruffled feathers.